高强度间歇训练对接受主动监测的前列腺癌患者心脏代谢生物标志物的影响:一项随机对照试验
ERASE试验将52名接受主动监测的前列腺癌患者随机分为高强度间歇训练(HIIT)组(n=26)和常规护理(UC)组(n=26),进行12周、每周3次、每次28-40分钟、强度为85-95% VO2peak的监督下渐进式有氧HIIT。HIIT组出席96%的计划训练课。与UC组相比,HIIT组总胆固醇、非高密度脂蛋白胆固醇、胰岛素、胰岛素样生长因子-1和胰岛素样生长因子结合蛋白-3显著改善,体重无显著组间变化。
要点
- 12周有氧HIIT改善了接受主动监测的前列腺癌患者的总胆固醇、非高密度脂蛋白胆固醇、胰岛素、IGF-1和IGFBP-3。
- HIIT组出席96%的计划训练课,体重无显著组间变化。
- 空腹血糖、HbA1c、其他脂质标志物、IGFBP-1、脂联素和瘦素无显著差异。
核心结论
- ERASE试验表明,12周有氧HIIT改善了接受主动监测的前列腺癌患者的若干心脏代谢生物标志物,可能有助于心血管健康获益并可能影响前列腺癌进展的信号通路。
- 需要进一步研究来确认运动对接受主动监测的前列腺癌男性心脏代谢标志物的影响,并确定这些影响是否与改善长期临床结局相关。
研究设计与样本
- ERASE试验为随机对照试验,将52名接受主动监测的前列腺癌男性随机分为HIIT组(n=26)或常规护理组(n=26)。
- HIIT干预为渐进式、监督下的有氧HIIT,强度为85-95% VO2peak,每次28-40分钟,每周3次,持续12周。
- 在基线和干预后采集血样分析心脏代谢生物标志物,使用协方差分析检验组间平均差异。
主要发现
- 干预后从49/52(94%)名参与者获得血液数据;参与者年龄63.4±7.1岁,40%为肥胖。
- HIIT组出席了96%的计划训练课;干预后未观察到体重显著的组间变化。
- 与常规护理组相比,HIIT组总胆固醇降低0.40 mmol/L(95%CI -0.70至-0.10;p=0.011)。
- 与常规护理组相比,HIIT组非高密度脂蛋白胆固醇降低0.35 mmol/L(95%CI -0.60至-0.11;p=0.006),胰岛素降低13.6 pmol/L(95%CI -25.3至-1.8;p=0.025)。
- 与常规护理组相比,HIIT组IGF-1降低15.0 ng/mL(95%CI -29.9至-0.1;p=0.048),IGFBP-3升高152.3 ng/mL(95%CI 12.6至292.1;p=0.033)。
局限性
- 需要进一步研究来确认运动对接受主动监测的前列腺癌男性心脏代谢标志物的影响,并确定这些影响是否与改善长期临床结局相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To report the effects of a 12-week high-intensity interval training (HIIT) program on cardiometabolic biomarkers in patients with prostate cancer on active surveillance (AS) from the Exercise During Active Surveillance for Prostate Cancer (ERASE) Trial. METHODS: Fifty-two men with prostate cancer on AS were randomized to either an exercise (HIIT; n = 26) or usual care (UC; n = 26) group. The HIIT intervention consisted of progressive, supervised, aerobic HIIT at an intensity of 85 to 95% VO2peak for 28 to 40 min per session performed three times/week for 12 weeks. Blood samples were collected at baseline and postintervention to analyze cardiometabolic biomarkers. Analysis of covariance was used to examine between-group mean differences. RESULTS: Blood data were obtained from 49/52 (94%) participants at postintervention. Participants were aged 63.4 ± 7.1 years and 40% were obese. The HIIT group attended 96% of the planned exercise sessions. No significant between-group changes in weight were observed after the intervention. Compared to UC, HIIT significantly improved total cholesterol (-0.40 mmol/L; 95% confidence interval[CI], -0.70 to -0.10; p = 0.011), non-high-density lipoprotein-c (-0.35 mmol/L; 95% CI, -0.60 to -0.11; p = 0.006), insulin (-13.6 pmol/L; 95% CI, -25.3 to -1.8; p = 0.025), insulin-like growth factor (IGF)-1 (-15.0 ng/mL; 95% CI, -29.9 to -0.1; p = 0.048), and IGF binding protein (IGFBP)-3 (152.3 ng/mL; 95% CI, 12.6 to 292.1; p = 0.033). No significant differences were observed for fasting glucose, HbA1c, other lipid markers, IGFBP-1, adiponectin, and leptin. CONCLUSIONS: The ERASE Trial showed that a 12-week aerobic HIIT program improved several cardiometabolic biomarkers in patients with prostate cancer on AS that may contribute to cardiovascular health benefits and potentially influence signaling pathways in the progression of prostate cancer. Further research is needed to confirm the effects of exercise on cardiometabolic markers in men with prostate cancer on AS and determine if these effects are associated with improved long-term clinical outcomes.
引用
- Kang DW, Field CJ, Patel D, et al. Effects of high-intensity interval training on cardiometabolic biomarkers in patients with prostate cancer undergoing active surveillance: a randomized controlled trial. Prostate Cancer Prostatic Dis. 2024. PMID: 39009705. doi:10.1038/s41391-024-00867-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。